The American College of Radiology is calling for greater transparency and explainability in AI algorithms for medical imaging.
Key Details
- 1ACR CEO Dana Smetherman emphasizes the need for AI explainability to build public trust.
- 2ACR supported Resolution 519 at the AMA House of Delegates 2025 meeting, requesting a framework for evidence-based AI transparency.
- 3The resolution was not adopted due to existing AMA policies, but highlighted ongoing concerns about AI 'black box' decision-making.
- 4ACR wants AI decisions to be explainable by qualified medical experts.
Why It Matters
As AI becomes more prevalent in radiology, transparent decision-making is crucial for safety, trust, and regulatory approval. ACR's stance elevates the conversation around explainability, directly impacting how future imaging AI systems may be developed and implemented.
Source
Radiology Business
Related News
•HealthExec
FDA Eases Path for AI in Clinical Decision Support and Healthcare Innovation
FDA publishes new guidance to promote innovation in general wellness and clinical decision support, impacting medical AI including radiology.
•AuntMinnie
FDA Guidance May Expand LLM Use in Radiology CDS
FDA updates its guidance, potentially enabling broader adoption of LLM-based clinical decision support software in radiology.
•AuntMinnie
Citizen Petition Proposes Streamlined FDA Pathway for Radiology AI
A petition urges the FDA to allow certain radiology AI software updates via postmarket study requirements instead of new 510(k) applications.